Executive Leadership


We’re a company focused on tackling some of the toughest health challenges. Our success is reflected in our management team, which is individually and collectively focused on improving the lives of individuals who are faced with debilitating diseases. Our management team are leaders in their respective fields, including research, development and commercialization, to name a few.

Robert Matsuk

President, North America and Global API

“We are inspired to provide product solutions for patients whose needs are not being fully addressed by treatments currently available. For decades, we have solved complex formulation, manufacturing and commercialization challenges, which has resulted in transformational medicines that address the needs of a changing healthcare industry and bring even greater benefits to partners and patients.”

Dr. Fred Grossman

President and Chief Medical Officer

“Drug discovery rarely occurs by any single, defined set of rules, nor does it always proceed as we would expect. Empowering our R&D staff in the context of a transparent, entrepreneurial culture where alternative approaches can be considered and implemented provides the ‘can do’ environment that motivates our staff, encourages debate and challenges our scientists and our clinicians.”

Robert Jackson

President, Global Innovative Product Development

“With our dynamic R&D organization, we are accelerating the development of our medicines to fully realize the extraordinary potential of our diverse, innovative pipeline. Within the next five years, we have the momentum to introduce new products, built on cutting-edge science, which will provide meaningful difference for the patients we serve.”

 

Our global executive leadership comprises the company’s top decision makers and is representative of the many countries in which we do business. Together, our leadership team is collectively focused on advancing Glenmark’s strategy and objectives. To learn more about our leadership team, click here.